Could cause temporary or reversible harm; serious harm is unlikely.
Cross- contamination with other products: The excipient, Crospovidone, NF is contaminated with theophylline
| Brand name | ESOMEPRAZOLE MAGNESIUM |
| Generic name | ESOMEPRAZOLE MAGNESIUM |
| Active ingredient(s) | ESOMEPRAZOLE MAGNESIUM DIHYDRATE |
| Distributed by / for | Cipla USA, Inc. 10 Independence Boulevard, Suite 300 Warren, NJ 07059 |
| NDC | 69097-529-34 |
| Full product label | Esomeprazole Magnesium for Delayed-Release Oral Suspension 40mg, packaged in unit dose packets, Rx only, Manufactured by: Cipla Ltd., Kurkumbh, India, Manufactured for: Cipla USA, Inc. 10 Independence Boulevard, Suite 300 Warren, NJ 07059 NDC 69097-529-34 |
| Recalling firm | CIPLA |
| Distribution | U.S.A. Nationwide |
| Quantity | 6,491 packets |
| Recall initiated | 2020-12-17 |
| Report date | 2021-01-06 |
| Recall completed | 2022-12-07 |
| Recall number | D-0183-2021 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Warren NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗